Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

Author:

Ascierto Paolo A.1,Long Georgina V.234,Robert Caroline5,Brady Benjamin6,Dutriaux Caroline7,Di Giacomo Anna Maria8,Mortier Laurent9,Hassel Jessica C.10,Rutkowski Piotr11,McNeil Catriona1213,Kalinka-Warzocha Ewa14,Savage Kerry J.15,Hernberg Micaela M.16,Lebbé Celeste17,Charles Julie1819,Mihalcioiu Catalin20,Chiarion-Sileni Vanna21,Mauch Cornelia22,Cognetti Francesco23,Ny Lars24,Arance Ana25,Svane Inge Marie2627,Schadendorf Dirk2829,Gogas Helen30,Saci Abdel31,Jiang Joel31,Rizzo Jasmine32,Atkinson Victoria3334

Affiliation:

1. Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy

2. Melanoma Institute Australia, Sydney, New South Wales, Australia

3. Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

4. Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia

5. Department of Medicine, Institute Gustave Roussy, Villejuif, France

6. Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia

7. Dermatology Service, University Hospital of Bordeaux, Bordeaux, France

8. UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy

9. Clinique de Dermatologie, Unité d’Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France

10. Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany

11. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute–Oncology Center, Warsaw, Poland

12. Chris O’Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales

13. Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

14. Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland

15. Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada

16. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

17. Assistance Publique–Hôpitaux de Paris Dermatology and Centre d’Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France

18. Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France

19. Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France

20. Department of Oncology, McGill University, Montreal, Quebec, Canada

21. Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy

22. Department of Dermatology, University Hospital Cologne, Cologne, Germany

23. Division of Oncology, Regina Elena Institute, Rome, Italy

24. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden

25. Hospital Clinic and Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

26. Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark

27. Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

28. Department of Dermatology, University Hospital Essen, Essen, Germany

29. German Cancer Consortium, Heidelberg, Germany

30. First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

31. Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey

32. Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey

33. Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia

34. Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 266 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3